Novartis Ag (NVSEF) Net Margin (2016 - 2025)
Historic Net Margin for Novartis Ag (NVSEF) over the last 17 years, with Q4 2025 value amounting to 388.65%.
- Novartis Ag's Net Margin rose 3636700.0% to 388.65% in Q4 2025 from the same period last year, while for Dec 2025 it was 497.63%, marking a year-over-year increase of 4705200.0%. This contributed to the annual value of 25.64% for FY2025, which is 19100.0% up from last year.
- According to the latest figures from Q4 2025, Novartis Ag's Net Margin is 388.65%, which was up 3636700.0% from 574.79% recorded in Q3 2025.
- In the past 5 years, Novartis Ag's Net Margin registered a high of 670.78% during Q1 2025, and its lowest value of 0.4% during Q2 2023.
- Its 5-year average for Net Margin is 123.08%, with a median of 25.69% in 2024.
- In the last 5 years, Novartis Ag's Net Margin plummeted by -1267100bps in 2022 and then surged by 6443200bps in 2025.
- Quarter analysis of 5 years shows Novartis Ag's Net Margin stood at 128.14% in 2021, then tumbled by -99bps to 1.43% in 2022, then surged by 3482bps to 51.14% in 2023, then tumbled by -51bps to 24.98% in 2024, then surged by 1456bps to 388.65% in 2025.
- Its Net Margin was 388.65% in Q4 2025, compared to 574.79% in Q3 2025 and 423.06% in Q2 2025.